BR0307540A - Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo - Google Patents

Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo

Info

Publication number
BR0307540A
BR0307540A BR0307540-0A BR0307540A BR0307540A BR 0307540 A BR0307540 A BR 0307540A BR 0307540 A BR0307540 A BR 0307540A BR 0307540 A BR0307540 A BR 0307540A
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparation
oral administration
film
active substances
active substance
Prior art date
Application number
BR0307540-0A
Other languages
English (en)
Inventor
Tina Rademacher
Frank Seiberts
Petra Brandt
Christian Von Falkenhausen
Markus Krumme
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of BR0307540A publication Critical patent/BR0307540A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PREPARAçãO FARMACêUTICA EM FORMA DE FILME OU EM FORMA DE LâMINA PARA ADMINISTRAR SUBSTâNCIAS ATIVAS, USO DA PREPARAçãO FARMACêUTICA E PROCESSO PARA A ADMINISTRAçãO ORAL DE SUBSTâNCIA (S) FARMACEUTICAMENTE ATIVA (S) DOTADAS DE SABOR AMARGO". A presente invenção refere-se a preparações farmacêuticas em forma de filme ou em forma de lâmina, para a administração oral das substâncias ativas que são caracterizadas em que a referida preparação contém pelo menos um polímero de formação de matriz que é dotado de pelo menos uma substância ativa e pelo menos uma substância de formação de dióxido de carbono dissolvido ou disperso na mesma.
BR0307540-0A 2002-02-21 2003-02-04 Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo BR0307540A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10207394A DE10207394B4 (de) 2002-02-21 2002-02-21 Geschmacksmaskierte oblatenförmige Arzneizubereitung
PCT/EP2003/001052 WO2003070227A1 (de) 2002-02-21 2003-02-04 Geschmacksmaskierte film- oder oblatenförmige arzneizubereitung

Publications (1)

Publication Number Publication Date
BR0307540A true BR0307540A (pt) 2004-12-07

Family

ID=27740294

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307540-0A BR0307540A (pt) 2002-02-21 2003-02-04 Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo

Country Status (17)

Country Link
US (1) US7615235B2 (pt)
EP (1) EP1476140B1 (pt)
JP (1) JP2005517722A (pt)
KR (1) KR100874876B1 (pt)
CN (1) CN1638748B (pt)
AU (1) AU2003210202B2 (pt)
BR (1) BR0307540A (pt)
CA (1) CA2472967C (pt)
DE (1) DE10207394B4 (pt)
ES (1) ES2666475T3 (pt)
IL (2) IL163653A0 (pt)
MX (1) MXPA04007980A (pt)
NZ (1) NZ534451A (pt)
PL (1) PL371058A1 (pt)
RU (1) RU2316316C2 (pt)
WO (1) WO2003070227A1 (pt)
ZA (1) ZA200405520B (pt)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
JP4643912B2 (ja) * 2004-01-30 2011-03-02 第一三共ヘルスケア株式会社 血流促進剤
CA2816904A1 (en) * 2004-02-17 2005-09-01 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20050186257A1 (en) * 2004-02-20 2005-08-25 Todd Manegold Dissolvable film and method of manufacture
US20060207911A1 (en) * 2005-03-15 2006-09-21 Bullock John D Emergency medical treatment system
WO2007034287A2 (en) * 2005-09-19 2007-03-29 University Of The Witwatersrand, Johannesburg Oramucosal pharmaceutical dosage form
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
BRPI0709382A2 (pt) * 2006-03-16 2011-07-12 Novartis Ag forma de dosagem sólida contendo um agente ativo de sabor mascarado
DE102006027790A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Typ-2-Diabetes Kombinations-Wafer
DE102006027794A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertonie-Kombinationswafer
DE102006027793A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Opioid-Kombinations-Wafer
DE102006027792A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antidepressiva-Kombinations-Wafer
DE102006027791A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag AchE-NMDA-Kombinationswafer
US20080008743A1 (en) * 2006-07-06 2008-01-10 Forest Laboratories Holdings Limited Orally Dissolving Formulations of Memantine
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
WO2008037809A1 (en) * 2006-09-29 2008-04-03 Abbott Gmbh & Co. Kg Transmucosal administration of fibrate compounds and delivery system therefor
JP4916894B2 (ja) * 2007-01-11 2012-04-18 株式会社ツキオカ フィルム状製剤及びフィルム状製剤の製造方法
WO2008112124A2 (en) * 2007-03-07 2008-09-18 Novartis Ag Orally administrable films
US9125836B2 (en) 2007-06-07 2015-09-08 Sato Pharmaceutical Co., Ltd. Film preparation with rapidly dissolving property and flexibility
US20090036413A1 (en) * 2007-07-31 2009-02-05 Bill Mcanalley Compositions, uses, and method of making wound care products from naturally occurring food ingredients
EP2244699A2 (en) * 2008-01-31 2010-11-03 Mcneil-PPC, Inc Edible film-strips for immediate release of active ingredients
WO2009099831A2 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips with modified release active ingredients
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
NZ586666A (en) * 2008-02-13 2012-04-27 Bayer Schering Pharma Ag Estradiol-containing drug delivery system
US8623401B2 (en) 2008-03-27 2014-01-07 Fenwafe Inc. Wafer formulation
US20090247644A1 (en) * 2008-03-28 2009-10-01 Forest Laboratories Holdings Limited Memantine formulations
US20110159058A1 (en) * 2008-08-25 2011-06-30 Kyukyu Pharmaceutical Co., Ltd. Film preparation containing loperamide hydrochloride
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
EP2419085A4 (en) * 2009-04-14 2013-04-24 Univ California IMPROVED DEVICES FOR ORAL MEDICINAL PRODUCTS AND MEDICINAL PRODUCTS
KR101074271B1 (ko) 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
CA2770334A1 (en) 2009-08-12 2011-02-17 Forest Laboratories Holdings Limited Orally disintegrating compositions of linaclotide
KR101063130B1 (ko) 2009-10-12 2011-09-07 조영재 이산화탄소 발생 시트 및 이의 제조방법
DK3254676T3 (en) 2009-10-30 2019-03-11 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
US12186426B2 (en) * 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US20110165254A1 (en) * 2010-01-07 2011-07-07 Knovation, Inc. Drug Delivery Using Fine Fiber Encapsulation
KR20130029758A (ko) * 2010-03-03 2013-03-25 코와 가부시키가이샤 불쾌한 맛을 갖는 약물을 함유하는 필름 제제
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
WO2011154975A2 (en) 2010-06-08 2011-12-15 Cadila Healthcare Limited Pharmaceutical compositions of metformin
WO2012003350A1 (en) * 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
DE102010049708A1 (de) 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US20130115266A1 (en) * 2011-11-04 2013-05-09 Bestsweet, Inc. Edible wafer-type product for delivery of nutraceuticals and pharmaceuticals
KR101188594B1 (ko) * 2011-12-06 2012-10-08 (주)씨엘팜 쓴맛이 차단된 실데나필 시트르산의 구강내 속붕해 필름제형
CN110496108A (zh) 2011-12-14 2019-11-26 Lts勒曼治疗系统股份公司 用于非诺贝特的具有提高的溶出度的糯米纸囊制剂和胶囊制剂
JP5841433B2 (ja) * 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
CN104168895B (zh) 2012-02-28 2020-02-21 首尔制药株式会社 包含西地那非作为活性成分的掩蔽苦味的高含量快速溶解膜
US20140272220A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Reduction in stress cracking of films
EP2815743A1 (en) * 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten formulations
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
WO2016163403A1 (ja) * 2015-04-07 2016-10-13 ニプロ株式会社 経口フィルム製剤
KR101686821B1 (ko) 2015-05-18 2016-12-15 (주)선재하이테크 X선 발생기
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
DE102020122557A1 (de) * 2020-08-28 2022-03-03 Lts Lohmann Therapie-Systeme Ag Mucosa-Perforierung
KR20230069951A (ko) * 2020-09-08 2023-05-19 쏜 헬스테크, 인크. 용해성 매트릭스
DE102021100752A1 (de) * 2021-01-15 2022-07-21 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
DE102021106491A1 (de) * 2021-03-17 2022-09-22 Lts Lohmann Therapie-Systeme Ag. Gerollte oral thin films mit hoher wirkstoffbeladung

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767571A1 (de) * 1968-06-04 1970-01-02 Farah Mfg Company Inc Waffelfoermiges Mundwaschmittel
IN142428B (pt) * 1974-07-05 1977-07-09 Schering Ag
US4184888A (en) * 1978-03-01 1980-01-22 Dap Inc. Effervescent adhesive-forming product
US4639368A (en) 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
MX9301817A (es) * 1992-03-30 1994-01-31 Alza Corp Sistema polimerico que contiene un compuesto parcialmente soluble.
IT1283029B1 (it) * 1996-05-17 1998-04-03 Resa Farma Composizioni farmaceutiche a base di diclofenac
US6063398A (en) * 1995-09-20 2000-05-16 L'oreal Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent
PT922464E (pt) * 1996-07-12 2005-07-29 Daiichi Seiyaku Co Materiais moldados por compressao rapidamente desintegraveis e processo para a sua producao
DE19635676A1 (de) * 1996-09-03 1998-03-05 Basf Ag Feste geschäumte Wirkstoffzubereitungen
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US20010006677A1 (en) * 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
EP1020193A4 (en) * 1997-09-30 2006-05-24 Daiichi Seiyaku Co ORAL PREPARATION
DE19802700A1 (de) 1998-01-24 1999-07-29 Bayer Ag Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US6497887B1 (en) * 2000-04-13 2002-12-24 Color Access, Inc. Membrane delivery system
DE10032456A1 (de) * 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
US8765167B2 (en) * 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20060057207A1 (en) * 2001-11-30 2006-03-16 Pfizer Inc Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene

Also Published As

Publication number Publication date
IL163653A0 (en) 2005-12-18
ES2666475T3 (es) 2018-05-04
IL163653A (en) 2011-07-31
DE10207394B4 (de) 2007-03-29
CN1638748B (zh) 2010-08-25
CA2472967A1 (en) 2003-08-28
WO2003070227A9 (de) 2004-04-01
EP1476140A1 (de) 2004-11-17
DE10207394A1 (de) 2003-09-11
US7615235B2 (en) 2009-11-10
WO2003070227A1 (de) 2003-08-28
RU2316316C2 (ru) 2008-02-10
JP2005517722A (ja) 2005-06-16
NZ534451A (en) 2006-11-30
EP1476140B1 (de) 2018-04-04
PL371058A1 (en) 2005-06-13
CN1638748A (zh) 2005-07-13
AU2003210202B2 (en) 2009-01-29
RU2004124720A (ru) 2005-06-10
AU2003210202A1 (en) 2003-09-09
CA2472967C (en) 2011-07-12
US20050163830A1 (en) 2005-07-28
KR20040089634A (ko) 2004-10-21
MXPA04007980A (es) 2005-08-15
ZA200405520B (en) 2005-02-23
KR100874876B1 (ko) 2008-12-19

Similar Documents

Publication Publication Date Title
BR0307540A (pt) Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
BR9909192A (pt) Preparações galênicas de meloxicam para administração oral
ES2109899T1 (es) Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos.
NO20070578L (no) Oral doseringsform sikret mot misbruk inneholdende (1,2R)-3-(3-dimetylammino-l-etyl-2-metyl-propyl)-fenol
UY27186A1 (es) Formulación farmacéutica
AR037255A1 (es) Composiciones farmaceuticas que contienen oxibutinina
NO863620D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
RU94022479A (ru) Применение антиэстрогенных соединений, а также фармацевтически приемлемых солей и сольватов для уменьшения концентрации глюкозы в крови, фармацевтический препарат
BR0111257A (pt) Formulação, e, uso de uma formulação
BR0314943A (pt) Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
BR0016801A (pt) Preparação antidiabética para administração oral
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
BR0210489A (pt) Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
BR0208421A (pt) Formulação farmacêutica para administração a um paciente através das mucosas, dose farmacêutica diária, dispersão sólida, uso de pvp em dispersão sólida com 4'-ciano-alfa', alfa', alfa'-trifluoro-3-(4-fluoro fenilsulfonil)-2-hidróxi-2-metilpropiono-m-toluidet o, e, métodos para aumentar a estabilidade em armazenagem, a biodisponibilidade da droga e para reduzir a variação de concentrações de plasma do 4'-ciano-alfa', alfa', alfa',-trifluoro-3-(4-fluorofenilsulfonil)-2-hidróxi-2 -metilpropiono-m-toluideto entre pacientes
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
BR9809571A (pt) Composição medicinal e processo para produzì-la
AR032783A1 (es) Una composicion farmaceutica para la administracion oral de un compuesto activo y un procedimiento para prepararla
BR0109747A (pt) Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
BR0111051A (pt) Produto farmacêutico e dose farmacêutica diária para administração a um paciente, regime de dose prover um efeito anti-androgênico e um efeito anti-estrogênico em um paciente, uso de um composto e de tamoxifeno ou de um sal ou solvato farmaceuticamente aceitável destes, e, método para prover um efeito anti-androgênico em um paciente

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 9/70, 9/46, 9/20; A61P 1/00

Ipc: A61K 9/70 (2011.01), A61K 9/46 (2011.01), A61K 9/2

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.